Pro-oxidant Treatment of Human Prostate Carcinoma (DU145) Induces Autoschizis Cell Death: Autophagosomes Build up out of Injured Endomembranes and Mitochondria

References

• Gilloteaux J, Jamison JM, Vijayalaksmi M, et al. SEM and TEM aspects of synergistic antitumor activity of Vitamin C- Vitamin K3 combinations against human prostatic carcinoma cells. Scanning Microsc Int 1995;9:159–73
   PubMedGoogle Scholar
• Gilloteaux J, Jamison JM, Ervin E, et al. Cancer cell necrosis by autoschizis: Synergism of antitumor activity of vitamin C: Vitamin K3 on human bladder carcinoma T24 cells. Scanning 1998;20:564–75
   PubMed Web of Science ®Google Scholar
• Jamison JM, Gilloteaux J, Venugopal M, et al. Flow cytometric and ultrastructural aspects of the synergistic antitumor activity of vitamin C- Vitamin K3 combinations against human prostatic carcinoma cells. Tissue Cell 1996;28:687–701
   PubMed Web of Science ®Google Scholar
• Jamison JM, Gilloteaux J, Taper HS, et al. The in vitro and in vivo antitumor activity of vitamin C:K3 combinations against prostate cancer. In: Lucas JL, ed. Trends in prostate cancer research. Hauppauge (NY): Nova Science; 2005:423–71
   Google Scholar
• Taper HS, Jamison JM, Gilloteaux J, et al. In vivo reactivation of DNases in implanted human prostate tumors after administration of a vitamin C: K3. J Histochem Cytochem 2001;49:109–19
   PubMed Web of Science ®Google Scholar
• Gilloteaux J, Jamison JL, Neal DR, Summers JL. Cell death by autoschizis in TRAMP prostate carcinoma cells as a result of treatment by ascorbate: Menadione combination. Ultrastruct Pathol 2005;28:221–36
   Web of Science ®Google Scholar
• Venugopal M, Jamison JM, Gilloteaux J, et al. Synergistic antitumor activity of vitamins C and K3 on human urologic tumor cell lines. Life Sci 1996;59:1389–400
   PubMed Web of Science ®Google Scholar
• Venugopal M, Jamison JM, Gilloteaux J, et al. Synergistic antitumor activity of vitamins C and K3 against human prostate carcinoma cell lines. Cell Biol Int 1996;20:787–97
   PubMed Web of Science ®Google Scholar
• Gilloteaux J, Jamison JM, Arnold D, Summers JL. Synergic antitumor cytotoxic actions of ascorbate and menadione on human prostate carcinoma (DU145) cells: In vitro: nucleus and other injuries preceding cell death by autoschizis. Ultrastruct Pathol 2014;38:116–40
   PubMed Web of Science ®Google Scholar
• Gilloteaux J, Jamison JM, McGuire K, et al. A rare, human prostate oncocyte cell originates from the prostatic carcinoma (DU145) cell line. Ultrastruct Pathol 2013;37:440–8
   PubMed Web of Science ®Google Scholar
• Gilloteaux J, Jamison JM, Neal DR, Summers JL. Xenotransplanted human prostate carcinoma (DU145) cells develop into carcinomas and cribriform carcinomas: Ultrastructural aspects. Ultrastruct Pathol 2012;36:294–311
   PubMed Web of Science ®Google Scholar
• Mickey DD, Stone KR, Wunderli H, et al. Heterotransplantation of a human prostatic adenocarcinoma cell line in nude mice. Cancer Res 1977;37:4049–58
   PubMed Web of Science ®Google Scholar
• Mickey DD, Stone KR, Wunderli H, et al. Characterization of a human prostate adenocarcinoma cell line (DU 145) as a monolayer culture and as a solid tumor in athymic mice. Progr Clin Biol Res 1980;37:67–84
   PubMedGoogle Scholar
• Stone KR, Mickey DD, Wunderli H, et al. Isolation of a human prostate carcinoma cell line (DU145). Int J Cancer 1978;21:274–81
   PubMed Web of Science ®Google Scholar
• Gonda MA, Aaronson SA, Ellmore N, et al. Ultrastructural studies of surface features of human normal and tumor cells in tissue culture by scanning and transmission electron microscopy. J Natl Cancer Inst 1976;56:245–63
   PubMedGoogle Scholar
• Gilloteaux J, Jamison JM, Arnold D, Summers JL. Scanning electron microscope characteristics of human prostate adenocarcinoma cell line (DU145) transplanted in nude mice. Scanning 1999;21:106–7
   Google Scholar
• Chakraborty J, Von Stein GA. Pleiomorphism of human prostatic cancer cells (DU145) in culture – the role of the cytoskeleton. Exp Mol Path 1986;44:235–49
   PubMed Web of Science ®Google Scholar
• Srigley JR, Hartwick WL. Selected ultrastructural aspects of urothelial and prostatic tumors. Ultrastruct Pathol 1988;12:49–65
   PubMed Web of Science ®Google Scholar
• Burchardt P. Ultrastrukturelle Untersuchuchungen am Prostatacarcinomzellen (I). Urologe A 1980;19:379–84
   PubMedGoogle Scholar
• Mao P, Nakao K, Angrist A. Human prostatic carcinoma: An electron microscope study. Cancer Res 1966;26:955–73
   PubMed Web of Science ®Google Scholar
• Brehmer B, Riemann JF, Bloodworth JM Jr, Madsen PO. Electron microscopic appearance of cells from carcinoma of the prostate in monolayer tissue culture. Urol Res 1973;1:27–31
   PubMedGoogle Scholar
• Gilloteaux J, Jamison JM, Arnold D, Summers JL. Human prostate DU145 carcinoma cells implanted in nude mice remove the peritoneal mesothelium to invade and grow as carcinomas. Anat Rec A Disc Mol Cell Evol Biol 2013;296:40–55
   Google Scholar
• Jerónimo C, Nomoto S, Caballero OL, et al. Mitochondrial mutations in early stage prostate cancer and bodily fluids. Oncogene 2001;20:5195–8
   PubMed Web of Science ®Google Scholar
• Herrmann PC, Gillespie JW, Charboneau L, et al. Mitochondrial proteome: Altered cytochrome c oxidase subunit levels in prostate cancer. Proteomics 2003;3:1801–10
   PubMed Web of Science ®Google Scholar
• Petros JA, Baumann AK, Ruiz-Pesini E, et al. MtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci USA 2005;102:719–24
   PubMed Web of Science ®Google Scholar
• Modica-Napolitano JS, Kulawiec M, Singh KK. Mitochondria and human cancer. Curr Mol Med 2007;7:121–31
   PubMed Web of Science ®Google Scholar
• Arismendi-Morrilo G. Electron microscopy morphology of the mitochondrial network in human cancer. Int J Biochem Cell Biol 2008;41:2062–8
   Google Scholar
• Kimbro KS, Simons JW. Hypoxia-inducible factor-1 in human breast and prostate cancer. Endocrine-Related Cancer 2006;13:739–49
   PubMed Web of Science ®Google Scholar
• Dakubo GD, Parr RL, Costello LC, et al. Altered metabolism and mitochondrial genome in prostate cancer. J Clin Pathol 2006;59:10–16
   PubMed Web of Science ®Google Scholar
• Warburg O. The metabolism of tumors. London: Constable Co Ltd; 1930
   Google Scholar
• Féron O. Pyruvate into lactate and back: From the Warburg effect to symbiotic energy fuel exchange in cancer cells. Radiother Oncol 2009;92:329–33
   PubMed Web of Science ®Google Scholar
• Dhup S, Dadhich RK, Porporato PE, Sonveaux P. Multiple biological activities of lactic acid in cancer: Influences of tumor growth, angiogenesis and metastasis. Curr Pharmacol Design 2012;18:1319–30
   PubMed Web of Science ®Google Scholar
• Chowdhury SKR, Gemin A, Singh G. High activity of mitochondrial glycerophosphate dehydrogenase and glycerophosphate-dependent ROS production in prostate cancer cell lines. Biochem Biophys Res Comm 2005;333:1139–45
   PubMed Web of Science ®Google Scholar
• Keller JM, Cablé S, el Bouhtoury F, et al. Peroxisome through cell differentiation and neoplasia. Biol Cell 1993;7:77–88
   Google Scholar
• Grogno DJ, Caplan R, Sarkar FH, et al. P53 status and prognosis of locally advanced prostatic adenocarcinoma: A study based on RTOG 8610. J Natl Cancer Inst 1997;89:158–65
   PubMedGoogle Scholar
• Zhou S, Kachhap S, Singh KK. Mitochondrial impairment in p53-deficient human cancer cells. Mutagenesis 2003;18:287–92
   PubMed Web of Science ®Google Scholar
• Karnovsky MJ. The fine structure of mitochondria in the frog nephron correlated with cytochrome oxidase activity. Exp Mol Pathol 1963;2:347–66
   PubMedGoogle Scholar
• Srikanth S, Franklin CC, Duke RC, Kraft RS. Human DU145 prostate cancer cells overexpressing mitogen-activated protein kinase phosphatase-1 are resistant to Fas ligand-induced mitochondrial perturbations and cellular apoptosis. Mol Cell Biochem 1999;199:169–78
   PubMedGoogle Scholar
• Mazor M, Kawano Y, Zhu H, et al. Inhibition of glycogen synthase kinase-3 represses androgen receptor activity and prostate cancer cell growth. Oncogene 2004;23:7882–92
   PubMedGoogle Scholar
• Darrington RS, Campa VM, Walker MM, et al. Distinct expression and activity of GSK-3α and GSK-3β in prostate cancer. Int J Cancer 2012;131:E872–83
   PubMed Web of Science ®Google Scholar
• Effert P, Beniers AJ, Tamimi Y, et al. Expression of glucose transporter (Glut-1) in cell lines and clinical specimens from human prostate adenocarcinoma. Anticancer Res 2004;24:3057–64, 83
   PubMed Web of Science ®Google Scholar
• Taper HS, Jamison JM, Gilloteaux J, et al. Inhibition of the development of metastases by dietary vitamin C: Vitamin K3 combination. Life Sci 2004;75:955–67
   PubMed Web of Science ®Google Scholar
• Noto V, Taper HS, Jiang YH, et al. Effects of sodium ascorbate (vitamin C) and 2-methyl-1,4-naphthoquinone (vitamin K3) treatment on human tumor cell growth in vitro. I. Synergism of combined vitamin C and K3 action. Cancer 1989;63:901–6
   PubMed Web of Science ®Google Scholar
• DeLoecker W, Janssens J, Bonte J, Taper HS. Effects of sodium ascorbate (vitamin C) and 2-methyl-1, 4-naphtoquinone (vitamin K3) treatment on human tumor cell growth in vitro. II. Synergism with combined chemotherapy action. Anticancer Res 1993;13:103–6
   PubMedGoogle Scholar
• Taper HS, Deckers CO, Deckers-Passau LO. Increase in nuclease activity as a possible means for detecting tumor cell sensitivity to anticancer agents. Cancer 1981;47:523–9
   PubMed Web of Science ®Google Scholar
• Taper HS, Keyeux A, Roberfroid M. Potentiation of radiotherapy by nontoxic treatment with combined vitamins C and K3 in mice bearing solid transplantable tumor. Anticancer Res 1996;16:499–503
   PubMed Web of Science ®Google Scholar
• Taper HS, de Gerlache J, Lans M, Roberfroid M. Non-toxic potentiation of cancer chemotherapy by combined C and K3 vitamin pretreatment. Int J Cancer 1987;40:575–9
   PubMed Web of Science ®Google Scholar
• Taper HS, Roberfroid M. Non-toxic sensitization of cancer chemotherapy by combined vitamin C and K3 pretreatment in a mouse tumor resistant to oncovin. Anticancer Res 1992;12:1651–4
   PubMed Web of Science ®Google Scholar
• Taper HS. Altered deoxyribonuclease activity in cancer cells and its role in non toxic adjuvant cancer therapy with mixed vitamins C and K3. Anticancer Res 2008;28:2727–32
   PubMed Web of Science ®Google Scholar
• Szent-Györgyi A. Observations on the function of peroxidise systems and the chemistry of the adrenal cortex. Description of a new carbohydrate derivative. Biochem J 1928;22:1387–409
   PubMedGoogle Scholar
• Maramag C, Menon M, Blaji KC, et al. Effects of vitamin C on prostate cancer cells in vitro: Effect on cell number, viability, and DNA synthesis. Prostate 1997;32:188–95
   PubMed Web of Science ®Google Scholar
• De Laurenzi V, Melino G, Savini I, et al. Cell death by oxidative stress and ascorbic acid regeneration in human neurectodermal cell lines. Eur J Cancer 1995;31:463–6
   Google Scholar
• Desai ID, Tappel AL. Damage to proteins by peroxidized lipids. J Lipid Res 1963;58:204–7
   Google Scholar
• Gilloteaux J, Jamison JM, Neal DR, et al. Cell damage and death by autoschizis in human bladder (RT4) carcinoma cells resulting from treatment by ascorbate and menadione. Ultrastruct Pathol 2010;34:140–60
   PubMed Web of Science ®Google Scholar
• Yamafuji K, Nakamura Y, Omura H, et al. Antitumor potency of ascorbic acid, dehydroascorbic or 2,3-diketogulonic acid and their action on deoxyribonucleic acid. Z Krebsforsch Onkol Cancer Res Clin Oncol 1971;76:1–7
   PubMedGoogle Scholar
• Valle VGR, Fagian MM, Parentoni LS, et al. The participation of reactive oxygen species and protein thiols in the mechanism of mitochondrial inner membrane permeabilization by calcium plus prooxidants. Arch Biochem Piophys 1993;307: 1–7
   PubMed Web of Science ®Google Scholar
• Atkinson DE. The energy charge of the adenylate pool as regulatory parameter. Interaction with feedback modifiers. Biochemistry 1968;7:4030–4
   PubMed Web of Science ®Google Scholar
• Porporato PE, Dhup S, Dadhich RK, et al. Anticancer targets in the glycolytic metabolism of tumors: A comprehensive review. Front Pharmacol 2011;2:(Article 49);1–18
   Google Scholar
• Leung PY, Miyashita K, Young M, Tsao CS. Cytologic effect of ascorbate and its derivatives on cultured malignant and nonmalignant cell lines. Anticancer Res 1993;13:475–80
   PubMed Web of Science ®Google Scholar
• Lupulescu A. Vitamin C inhibits DNA, RNA and protein synthesis in epithelial neoplastic cells. Int J Vitam Nutr Res 1991;61:125–9
   PubMedGoogle Scholar
• Koch CJ, Biaglow JE. Toxicity, radiation sensitivity modification and metabolic effects of dehydroascorbate and ascorbate in mammalian cells. J Cell Physiol 1978;94:299–306
   PubMed Web of Science ®Google Scholar
• Fort L, Taper HS, Brucher JM. Nucleases activity in different segments of the human digestive tyube compared to the incidence of carcinomas (histochemical study). Histochemie 1969;20:150–8
   PubMedGoogle Scholar
• McGuire K, Jamison JM, Neal D, et al. Elucidating the pathway of Apatone® induced DNase II reactivation during autoschizic cell death. Microsc Microanal 2009;15:888–9
   Web of Science ®Google Scholar
• Shpak M, Kugelman JR, Varela-Ramirez A, Aguilera RJ. The phylogeny and evolution of deoxyribonuclease II: An enzyme essential for lysosomal DNA degradation. Mol Phylogenet Evol 2008;47:841–54
   PubMed Web of Science ®Google Scholar
• Cameron E, Pauling L. The orthomolecular treatment of cancer. I. The role of ascorbic acid in host resistance. Chem Biol Interact 1974;9:273–83
   PubMed Web of Science ®Google Scholar
• Wattenberg LW, Leong JL. Effects of coenzyme Q10 and menadione on succinic dehydrogenase activity as measured by tetrazolium salt reduction. J Histochem Cytochem 1960;8:296–303
   PubMed Web of Science ®Google Scholar
• Taper HS. Evaluation of the validity of the histochemical lead nitrate technique for alkaline and acid deoxyribonuclease. J Histochem Cytochem 1979;27:1483–90
   PubMed Web of Science ®Google Scholar
• Dallner G, Ernster L. Abolition of the crabtree effect in Ehlich ascites tumors by vitamin K-3. Exp Cell Res 1962;27:368–72
   PubMedGoogle Scholar
• Wu FY, Chang NT, Chen WJ, Juan CC. Vitamin K3-induced cell cycle arrest and apoptotic cell death are accompanied by altered expression of c-fos and c-myc in nasopharyngeal carcinoma cells. Oncogene 1993;8:2237–44
   PubMed Web of Science ®Google Scholar
• Calderon PB, Cadrobi J, Marques C, et al. Potential therapeutic application of the association of vitamins C and K3 in cancer treatment. Curr Med Chem 2002;9:2271–85
   PubMed Web of Science ®Google Scholar
• Verrax J, Cadrobbi J, Delvaux M, et al. The association of vitamins C and K3 kills cancer cells mainly by autoschizis, a novel form of cell death. Eur J Med Chem 2003;38:451–7
   PubMed Web of Science ®Google Scholar
• Scott GK, Atsriku C, Kaminker P, et al. Vitamin K3 (menadione)-induced oncosis associated with keratin 8 phosphorylation and histone H3 arylation. Mol Pharmacol 2005;68:606–15
   PubMed Web of Science ®Google Scholar
• Gerasimenko JV, Gerasimenko OV, Palejwala A, et al. Menadione-induced apoptosis: Roles of cytosolic Ca2+ elevations and the mitochondrial permeability transition pore. J Cell Sci 2002;115:485–97
   PubMed Web of Science ®Google Scholar
• Zerbes RM, van der Klei IJ, Veenhuis M, et al. Mitofilin complexes: Conserved organizers of mitochondrial membrane architecture. J Biol Chem 2012;393:1247–61
   Google Scholar
• Gilloteaux J, Naud J. The zinc iodide-osmium tetroxide staining-fixative of Maillet. Nature of the precipitate studied by x-ray microanalysis and detection of Ca2+-affinity subcellular sites in a tonic smooth muscle. Histochemistry 1979;63:227–43
   PubMedGoogle Scholar
• Kim I, Rodriguez-Enriquez S, Lemasters JJ. Selective degradation of mitochondria by mitophagy. Arch Biochem Biophys 2007;462:245–53
   PubMed Web of Science ®Google Scholar
• Gewies A, Rocklin OW, Cohen MB. Ceramide induces cell death in the human prostatic carcinoma cell lines PC3 and DU145 but does not seem to be involved in Fas-mediated apoptosis. Lab Invest 2000;80:671–6
   PubMedGoogle Scholar
• Franke WW, Kartenbeck J. Outer mitochondrial membrane continuous with endoplasmic reticulum. Protoplasma 1971;73:35–41
   PubMedGoogle Scholar
• Higgins LH, Withers HG, Garbens A, et al. Hypoxia and the metabolic phenotype of prostate cancer cells. Biochim Biophys Acta 2009;1787:1433–43
   PubMed Web of Science ®Google Scholar
• Jarabak R, Jarabak J. Effect of ascorbate on the DT-diaphorase-mediated redox cycling of 2-methyl-1, 4-naphthoquinone. Arch Biochem Biophys 1995;318:418–23
   PubMedGoogle Scholar
• Xu R, Pelicano H, Zhou Y, et al. Inhibition of glycolysis in cancer cells: A novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res 2005;65:613–21
   PubMed Web of Science ®Google Scholar
• Ericsson JLE, Trump BF, Weibel J. Electron microscopic studies of the proximal tubule of the rat kidney. II Cytosegresomes and cytosomes. Their relationship to each other and the lysosome concept. Lab Invest 1965;14:1341–65
   PubMedGoogle Scholar
• Novikoff AB, Shin W-Y. Endoplasmic reticulum and autophagy in rat hepatocytes. Proc Natl Acad Sci USA 1978;75:5039–42
   PubMed Web of Science ®Google Scholar
• Van Caneghem P. Influence of substances with thiol functions and their reagents on the fragility lysosomes. Biochem Pharmacol 1972;21:2417–24
   PubMedGoogle Scholar
• Arrick BA, Nathan CF, Griffith OW, Cohn ZA. Glutathione depletion sensitizes tumor cells to oxidative cytolysis. J Biol Chem 1982;257:1231–7
   PubMed Web of Science ®Google Scholar
• Axe EL, Walker SA, Manifava M, et al. Autophagosome formation from membrane compartments enriched in phosphatidylinositol 3-phosphate and dynamically connect to the endoplasmic reticulum. J Cell Biol 2008;182:685–701
   PubMed Web of Science ®Google Scholar
• Tooze SA, Yoshimori T. The origin of the autophagosomal membrane. Nat Cell Biol 2010;12:831–5
   PubMed Web of Science ®Google Scholar
• Ylä-Antilla P, Vihinen H, Jokitalo E, Eskelinen E-L. 3D tomography reveals connections between the phagophore and endoplasmic reticulum. Autophagy 2009;5:1180–5
   PubMedGoogle Scholar
• DeBrito OM, Scorrano L. An intimate liaison: Spatial organization of the endoplasmic reticulum-mitochondria relationship. EMBO J 2010;29:2715–23
   PubMedGoogle Scholar
• Hailey DW, Kim PK, Satpute-Krishnan P, et al. Mitochondria supply membranes for autophagosome biogenesis during starvation. Cell 2010;141:656–67
   PubMed Web of Science ®Google Scholar
• Gilloteaux J, Kashouty R, Yono N. The perinuclear space of pancreatic acinar cells and the synthetic pathway of zymogen in Scorpaena scrofa L.: Ultrastructural aspects. Tissue Cell 2008;40:7–20
   PubMed Web of Science ®Google Scholar
• Hamasaki M, Furuta N, Matsuda A, et al. Autophagosomes form at ER-mitochondria contact sites. Nature 2013;495:389–93
   PubMed Web of Science ®Google Scholar
• Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature 2008;451:1069–75
   PubMed Web of Science ®Google Scholar
• Noda T, Fujita N, Yoshimori T. The late stages of autophagy: How does the end begin? Cell Death Differ 2009;16:984–90
   PubMed Web of Science ®Google Scholar
• Lasalvia-Prisco E, Cucci S, Vásquez J, et al. Serum markers consistent with autoschizis induced by ascorbic acid- menadione in patients with prostate cancer. Med Oncol 2002;20:45–52
   Google Scholar
• Tareen B, Summers JL, Jamison JM, et al. A 12 week, open label, phase I/IIa study using APATONE for the treatment of prostate cancer patients who have failed standard therapy. Int J Med Sci 2008;5:62–7
   PubMedGoogle Scholar